Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria (Q61456193)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

author name string

M Praga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

E Hernández

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

C Montoyo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

A Andrés

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

J L Rodicio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 September 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

20 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

240-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

20 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Angiotensin converting enzyme inhibitors: the end of end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Nephrotic Proteinuria Without Hypoalbuminemia: Clinical Characteristics and Response to Angiotensin-Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Antiproteinuric effect of captopril in primary glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Renal effects of enalapril in hypertensive patients with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Chronic effects of dietary protein in the rat with intact and reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Effects of antihypertensive drugs on glomerular morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Kinetics of immune deposits in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

The Nature of the Glomerular Injury in Minimal Change and Focal Sclerosing Glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Converting enzyme inhibition in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980696-2

7 January 2021

10.1016/S0272-6386(12)80696-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1519604%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference